Recent News

• 08.13.2026 - Arcadia Biosciences Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
• 06.13.2026 - Arcadia Biosciences Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
• 06.12.2026 - Arcadia Biosciences Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
• 08.14.2025 - Arcadia Biosciences Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
• 08.14.2025 - Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights
• 05.08.2025 - Q1 2025 Financial Results and Business Highlights Conference Call
• 05.08.2025 - Arcadia Biosciences Announces First Quarter 2025 Financial Results and Business Highlights
• 05.08.2025 - Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights
• 04.29.2025 - Arcadia Biosciences Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
• 04.29.2025 - Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call

Recent Filings

• 08.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.13.2026 - 8-K Current report
• 08.13.2026 - EX-99.1 EX-99.1
• 08.10.2026 - DEF 14A Other definitive proxy statements
• 08.10.2026 - 8-K Current report
• 08.10.2026 - ARS Annual Report to Security Holders
• 07.31.2026 - PRE 14A Other preliminary proxy statements
• 07.09.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 07.08.2026 - EFFECT Notice of Effectiveness
• 07.02.2026 - 8-K Current report